BCRX
BioCryst Pharmaceuticals, Inc.
8.16
USD
This page is just a preview of the data found in TrendSpider’s full version
BioCryst Pharmaceuticals, Inc. stock is down -17.96% since 30 days ago. The next earnings date is Nov 2, 2026. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 32 September’s closed higher than August. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 50% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 27 Aug 14:16 | 18 Sep, 2026 | 12.00 | 8212 | ||
| 27 Aug 14:24 | 18 Sep, 2026 | 11.00 | 8789 | ||
| 27 Aug 16:10 | 18 Sep, 2026 | 9.00 | 2180 | ||
| 27 Aug 18:17 | 21 Jan, 2028 | 10.00 | 754 | ||
| 27 Aug 18:20 | 15 Jan, 2027 | 10.00 | 9956 | ||
| 28 Aug 19:05 | 18 Sep, 2026 | 9.00 | 3029 | ||
| 31 Aug 14:25 | 18 Dec, 2026 | 10.00 | 200 | ||
| 01 Sep 16:15 | 15 Jan, 2027 | 10.00 | 10024 | ||
| 04 Sep 19:16 | 18 Sep, 2026 | 11.00 | 11649 | ||
| 08 Sep 14:36 | 15 Jan, 2027 | 10.00 | 10016 |
-
RBC CapitalThu Sep 10, 16:35
-
NeedhamTue Sep 8, 19:31
-
Jon Stonehouse, Directorshares awarded
-
Jill Milne, Directorshares awarded
-
VINCENT MILANO, Directorshares awarded
-
Amy McKee, Directorshares awarded
-
Steven Frank, Directorshares awarded
Looking for a new broker?
Today’s Movers and Shakers
Join Our Market Watch Newsletter!
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!
